11/06/2025 | Press release | Distributed by Public on 11/06/2025 15:24
Filed Pursuant to Rule 424(b)(3)
File No. 333-277540
Up to $300,000,000
Common Stock
Supplement No. 5, dated November 6, 2025
to
Prospectus, dated May 8, 2024
Prospectus Supplement, dated May 9, 2024
This supplement amends, supplements or modifies certain information contained in the prospectus supplement, dated May 9, 2024 (the "ATM Prospectus Supplement"), and the accompanying prospectus, dated May 8, 2024 (the "Base Prospectus" and together with the ATM Prospectus Supplement, any supplements thereto and the documents deemed incorporated by reference in each, the "Prospectus"), which relate to the sale of shares of common stock of Fidus Investment Corporation in an "at-the-market" offering (the "ATM Program") pursuant to the equity distribution agreement, dated November 10, 2022 and as amended from time to time, with Raymond James & Associates, Inc. ("Raymond James") and B. Riley Securities, Inc. ("B. Riley" and together with Raymond James, the "Sales Agents"). Capitalized terms used but not defined herein shall have the same meaning given them in the ATM Prospectus Supplement.
You should carefully read the entire Prospectus and this supplement before investing in our common stock. This supplement should be read in conjunction with the Prospectus. You should also carefully consider the information set forth under the sections titled "Risk Factors" on page 11 of the Base Prospectus and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is incorporated by reference into the Prospectus, as well as in our subsequent filings with the U.S. Securities and Exchange Commission ("SEC") that are incorporated into the Prospectus, before investing in our common stock.
STATUS OF THE "AT-THE-MARKET" OFFERING
From November 10, 2022 to September 30, 2025, we sold a total of 11,693,846 shares of our common stock under the ATM Program for gross proceeds of approximately $233.5 million and net proceeds of approximately $230.3 million, after deducting commissions to the Sales Agents on shares sold and offering expenses.
As of November 4, 2025, approximately $64.9 million in aggregate amount of our common stock remains available for sale under the ATM Program.
FEES AND EXPENSES
The following table is intended to assist you in understanding the costs and expenses that an investor in our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this supplement contains a reference to fees or expenses paid by "us" or that "we" will pay fees or expenses, common stockholders will indirectly bear such fees or expenses.
|
Stockholder transaction expenses: |
||||
|
Sales load (as a percentage of offering price) |
1.50 |
% |
(1) |
|
|
Offering expenses borne by us (as a percentage of offering price) |
0.32 |
% |
(2) |
|
|
Dividend reinvestment plan expenses |
- |
(3) |
||
|
Total stockholder transaction expenses paid by us (as a percentage of offering price) |
1.82 |
% |
||
|
Annual expenses (as a percentage of net assets attributable to common stock) (4): |
||||
|
Base management fee |
2.98 |
% |
(5) |
|
|
Incentive fees payable under Investment Advisory Agreement |
2.75 |
% |
(6) |
|
|
Interest payments on borrowed funds |
4.12 |
% |
(7) |
|
|
Other expenses |
1.23 |
% |
(8) |
|
|
Total annual expenses, before base management fee waiver |
11.08 |
% |
(9) |
|
|
Base management fee waiver |
(0.03 |
%) |
(10) |
|
|
Total annual expenses, net of base management fee waiver |
11.05 |
% |
(11) |
|
The incentive fee consists of two parts:
The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and a "catch-up" provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, the Adviser receives no incentive fee until our pre-incentive fee net investment income equals the hurdle rate of 2.0% but then receives, as a "catch-up," 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if pre-incentive fee net investment income exceeds 2.5% in any calendar quarter, the Adviser will receive 20.0% of our pre-incentive fee net investment income as if a hurdle rate did not apply.
The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable
under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation. See Part I, Item 1. "Business-Management and Other Agreements-Investment Advisory Agreement" in our most recent Annual Report on Form 10-K.
Example
The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed we would have no additional leverage and that our annual operating expenses would remain at the levels set forth in the table above, including giving effect to the management fee waiver described in the table above. The stockholder transaction expenses described above are included in the following examples.
|
1 year |
3 years |
5 years |
10 years |
|||||
|
You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return |
$ |
125 |
$ |
321 |
$ |
493 |
$ |
841 |
|
You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return resulting entirely from net realized capital gains (all of which is subject to our incentive fee on capital gains) |
$ |
135 |
$ |
343 |
$ |
523 |
$ |
874 |
The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5.0% annual return, our performance will vary and may result in a return greater or less than 5.0%. Assuming a 5.0% annual return, the incentive fee under the Investment Advisory Agreement would either not be payable or have an insignificant impact on the expense amounts shown above. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all distributions at net asset value ("NAV"), if our board of directors authorizes and we declare a cash dividend, participants in our dividend reinvestment plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the distribution. See Part II, Item 5. "Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities" in our most recent Annual Report on Form 10-K for additional information regarding our dividend reinvestment plan.
These examples and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown.
PRICE RANGE OF COMMON STOCK
Our common stock began trading on June 21, 2011 on the Nasdaq Global Market under the symbol "FDUS." Effective January 3, 2012, our common stock was included in the Nasdaq Global Select Market. The following table lists the high and low closing sale price for our common stock, and the closing sale price as a percentage of NAV on our common stock for each fiscal quarter during the last two most recently completed fiscal years and each full fiscal quarter since the beginning of the current fiscal year.
|
Period |
NAV(1) |
High Closing Sales Price |
Low Closing Sales Price |
Premium / (Discount) of High Sales Price to NAV(2) |
Premium / (Discount) of Low Sales Price to NAV(2) |
|||||||||||||||||||||
|
Year Ended December 31, 2025: |
||||||||||||||||||||||||||
|
First Quarter |
$ |
19.39 |
$ |
23.37 |
$ |
20.39 |
20.5 |
% |
5.2 |
% |
||||||||||||||||
|
Second Quarter |
19.57 |
20.65 |
17.32 |
5.5 |
(11.5 |
) |
||||||||||||||||||||
|
Third Quarter |
19.56 |
21.99 |
20.18 |
12.4 |
3.2 |
|||||||||||||||||||||
|
Fourth Quarter (through November 4, 2025) |
* |
21.07 |
19.31 |
* |
* |
|||||||||||||||||||||
|
Year Ended December 31, 2024: |
||||||||||||||||||||||||||
|
First Quarter |
$ |
19.36 |
$ |
20.04 |
$ |
18.79 |
3.5 |
% |
(2.9 |
) |
% |
|||||||||||||||
|
Second Quarter |
19.50 |
20.47 |
19.26 |
5.0 |
(1.2 |
) |
||||||||||||||||||||
|
Third Quarter |
19.42 |
20.34 |
18.76 |
4.7 |
(3.4 |
) |
||||||||||||||||||||
|
Fourth Quarter |
19.33 |
21.49 |
19.10 |
11.2 |
(1.2 |
) |
||||||||||||||||||||
|
Year Ended December 31, 2023: |
||||||||||||||||||||||||||
|
First Quarter |
$ |
19.39 |
$ |
20.90 |
$ |
18.29 |
7.8 |
% |
(5.7 |
) |
% |
|||||||||||||||
|
Second Quarter |
19.13 |
20.08 |
18.10 |
5.0 |
(5.4 |
) |
||||||||||||||||||||
|
Third Quarter |
19.28 |
20.98 |
18.80 |
8.8 |
(2.5 |
) |
||||||||||||||||||||
|
Fourth Quarter |
19.37 |
20.13 |
17.69 |
3.9 |
(8.7 |
) |
||||||||||||||||||||
* NAV has not yet been determined.
On November 4, 2025, the last reported sales price of our common stock was $20.61 per share. As of November 4, 2025, we had approximately 16 stockholders of record.
Shares of BDCs may trade at a market price that is less than the NAV of those shares. The possibility that our shares of common stock will trade at a discount from NAV or at premiums that are unsustainable over the long term are separate and distinct from the risk that our NAV will decrease. It is not possible to predict whether any common stock offered pursuant to this prospectus supplement will trade at, above or below NAV.